Kevin Slayton v. HHS - Influenza, Guillain-Barre Syndrome (2025)

On September 27, 2021, Kevin Slayton filed a petition under the National Vaccine Injury Compensation Program alleging that the influenza vaccine he received on September 27, 2018, caused him to develop Guillain-Barre Syndrome (GBS). The respondent, the Secretary of Health and Human Services, denied that Mr.

Slayton sustained GBS or any other injury caused by the vaccine. Despite this denial, the parties filed a stipulation on April 1, 2025, agreeing that a decision should be entered awarding compensation to the petitioner.

Special Master Herbrina D.S. Young reviewed the stipulation and found it reasonable, adopting it as the decision of the Court.

The stipulation provided for a lump sum payment of $25,000.00 to be paid through an ACH deposit to petitioner's counsel's IOLTA account for prompt disbursement to Mr. Slayton.

This amount was stipulated as compensation for all damages available under the program. The decision was issued on May 2, 2025, and judgment was entered accordingly.

Petitioner was represented by Howard Spessard Stevens of Pascale Stevens, LLC, and respondent was represented by Jamica Marie Littles of the United States Department of Justice. The public decision does not describe the onset of symptoms, specific clinical details, medical tests, treatments, or expert witnesses.